New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride

Cary O HardingDepartments of Molecular and Medical Genetics and Pediatrics, Oregon Health & Science University, Portland, Oregon, USAAbstract: Oral administration of sapropterin hydrochloride, recently approved for use by the US Food and Drug Administration and the European Commission, i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Cary O Harding
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/8ad2204159d240fd8108f9cd8765077a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares